Insider Transactions in Q1 2021 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
475,000
+19.89%
|
$8,075,000
$17.0 P/Share
|
|
Feb 09
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,200,133
+50.0%
|
-
|
|
Feb 09
2021
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
475,000
+11.13%
|
$8,075,000
$17.0 P/Share
|
|
Feb 09
2021
|
Carl L Gordon Director |
BUY
Conversion of derivative security
|
Indirect |
3,316,204
+50.0%
|
-
|
|
Feb 09
2021
|
Lav Biosciences Fund V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,781,566
+50.0%
|
-
|
|
Feb 09
2021
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
475,000
+11.13%
|
$8,075,000
$17.0 P/Share
|
|
Feb 09
2021
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
3,316,204
+50.0%
|
-
|
|
Feb 09
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
665,000
+21.82%
|
$11,305,000
$17.0 P/Share
|
|
Feb 09
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,717,033
+50.0%
|
-
|